Dehydroepiandrosterone inhibits the spontaneous release of superoxide radical by alveolar macrophages in vitro in asbestosis.
Asbestosis is characterized by an alveolar macrophage alveolitis with injury and fibrosis of the lower respiratory tract. Alveolar macrophages recovered by bronchoalveolar lavage spontaneously release exaggerated amounts of oxidants including superoxide anion and hydrogen peroxide that may mediate alveolar epithelial cell injury. Dehydroepiandrosterone (DHEA) is a normally occurring adrenal androgen that inhibits glucose-6-phosphate dehydrogenase, the initial enzyme in the pentose phosphate shunt necessary for NADPH generation and superoxide anion formation. In this regard, we hypothesized that DHEA may reduce asbestos-induced oxidant release. DHEA added in vitro to alveolar macrophages lavaged from 11 nonsmoking asbestos workers significantly reduced superoxide anion release. DHEA was measured in bronchoalveolar lavage and found to be similar to serum concentrations. DHEA is an antioxidant and potential anticarcinogenic agent that may have a therapeutic role in reducing the increased oxidant burden in asbestos-induced alveolitis of the lower respiratory tract.
Rom
W N
WN
Department of Medicine, New York University Medical Center, New York 10016.
Harkin
T
T
D001195:Asbestosis / Q000378:metabolism* / Q000473:pathology; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D003687:Dehydroepiandrosterone / Q000032:analysis / Q000097:blood / Q000494:pharmacology*; D005609:Free Radicals; D006801:Humans; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D008875:Middle Aged; D011650:Pulmonary Alveoli / Q000378:metabolism / Q000473:pathology; D013481:Superoxides / Q000378:metabolism*
D005609:Free Radicals; D013481:Superoxides; D003687:Dehydroepiandrosterone